Class information for:
Level 1: NON INFERIORITY MARGIN//NON INFERIORITY//THREE ARM DESIGN

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
20404 400 22.2 59%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1692 6172 FAMILYWISE ERROR RATE//MULTIPLE TESTING//FALSE DISCOVERY RATE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 NON INFERIORITY MARGIN Author keyword 24 82% 4% 14
2 NON INFERIORITY Author keyword 18 24% 17% 66
3 THREE ARM DESIGN Author keyword 17 100% 2% 8
4 NONINFERIORITY MARGIN Author keyword 15 68% 3% 13
5 ACTIVE CONTROL TRIALS Author keyword 12 86% 2% 6
6 CONSTANCY ASSUMPTION Author keyword 12 86% 2% 6
7 FIXED MARGIN METHOD Author keyword 11 100% 2% 6
8 PUTATIVE PLACEBO Author keyword 8 100% 1% 5
9 THREE ARM TRIAL Author keyword 6 80% 1% 4
10 ACTIVE CONTROL TRIAL Author keyword 6 71% 1% 5

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 NON INFERIORITY MARGIN 24 82% 4% 14 Search NON+INFERIORITY+MARGIN Search NON+INFERIORITY+MARGIN
2 NON INFERIORITY 18 24% 17% 66 Search NON+INFERIORITY Search NON+INFERIORITY
3 THREE ARM DESIGN 17 100% 2% 8 Search THREE+ARM+DESIGN Search THREE+ARM+DESIGN
4 NONINFERIORITY MARGIN 15 68% 3% 13 Search NONINFERIORITY+MARGIN Search NONINFERIORITY+MARGIN
5 ACTIVE CONTROL TRIALS 12 86% 2% 6 Search ACTIVE+CONTROL+TRIALS Search ACTIVE+CONTROL+TRIALS
6 CONSTANCY ASSUMPTION 12 86% 2% 6 Search CONSTANCY+ASSUMPTION Search CONSTANCY+ASSUMPTION
7 FIXED MARGIN METHOD 11 100% 2% 6 Search FIXED+MARGIN+METHOD Search FIXED+MARGIN+METHOD
8 PUTATIVE PLACEBO 8 100% 1% 5 Search PUTATIVE+PLACEBO Search PUTATIVE+PLACEBO
9 THREE ARM TRIAL 6 80% 1% 4 Search THREE+ARM+TRIAL Search THREE+ARM+TRIAL
10 ACTIVE CONTROL TRIAL 6 71% 1% 5 Search ACTIVE+CONTROL+TRIAL Search ACTIVE+CONTROL+TRIAL

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 NON INFERIORITY TRIALS 41 61% 11% 43
2 NONINFERIORITY TRIALS 21 73% 4% 16
3 ACTIVE CONTROL TRIALS 12 26% 10% 40
4 ACTIVE CONTROLLED TRIALS 11 69% 2% 9
5 EQUIVALENCE RANDOMIZED TRIALS 10 44% 5% 18
6 EQUIVALENCE TRIALS 7 41% 4% 14
7 ESTABLISHING EFFICACY 6 80% 1% 4
8 PLACEBO ARM 6 71% 1% 5
9 NON INFERIORITY 6 13% 11% 43
10 ASSESSING NON INFERIORITY 6 100% 1% 4

Journals

Reviews



Title Publ. year Cit. Active
references
% act. ref.
to same field
Through the looking glass: understanding non-inferiority 2011 31 10 70%
How to Demonstrate Similarity by Using Noninferiority and Equivalence Statistical Testing in Radiology Research 2013 18 29 17%
Methodology of superiority vs. equivalence trials and non-inferiority trials 2007 46 18 44%
The draft FDA guideline on non-inferiority clinical trials: a critical review from European pharmaceutical industry statisticians 2011 10 4 75%
Non-inferiority study design: lessons to be learned from cardiovascular trials 2012 18 24 46%
Evaluating "superiority", "'equivalence" and "non-inferiority" in clinical trials 2007 4 5 100%
Making sense of noninferiority: A clinical and statistical perspective on its application to cardiovascular clinical trials 2007 14 28 54%
Issues on the selection of non-inferiority margin in clinical trials 2009 4 17 71%
Systematic evaluation of non-inferiority and equivalence randomized trials of anti-infective drugs 2013 2 21 38%
Reviewing statistical analysis plans - A guide for medical writers 2006 0 2 100%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 PHARMACEUT LOGIST 2 67% 0.5% 2
2 OPASS 2 50% 0.8% 3
3 BIOMETR 1 2 18% 2.5% 10
4 OBOPASS 1 100% 0.5% 2
5 BIOMETR 6 1 20% 1.5% 6
6 BIOMETR 2 1 23% 1.3% 5
7 OB OTS CDER 1 30% 0.8% 3
8 EPIDEMIOL SURVEILLANCE UNIT EPI 1 33% 0.5% 2
9 QUANTITAT METHODS INFORMAT SCI 1 33% 0.5% 2
10 HTA UNIT 1 16% 1.0% 4

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000193050 UNCONDITIONAL TEST//2 X 2 TABLES//AGRESTI COULL INTERVAL
2 0.0000177590 BRIDGING STUDY//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL
3 0.0000173911 INDIVIDUAL BIOEQUIVALENCE//HIGHLY VARIABLE DRUGS//BIOEQUIVALENCE
4 0.0000106099 CONDITIONAL POWER//INTERIM ANALYSIS//SAMPLE SIZE RE ESTIMATION
5 0.0000084606 EQUIPOISE//SHAM SURGERY//DEVELOPING WORLD BIOETHICS
6 0.0000075398 FALSE DISCOVERY RATE//MULTIPLE TESTING//FAMILYWISE ERROR RATE
7 0.0000073451 PARALLEL LINE BIOASSAY//SLOPE RATIO BIOASSAY//FIELLER METHOD
8 0.0000072308 CONSORT//OTTAWA METHODS//REPORTING QUALITY
9 0.0000065319 PLACEBO ANALGESIA//NOCEBO//PLACEBO
10 0.0000057287 BIOSTATISTICS KNOWLEDGE//AQUACULTURE RESEARCH//BASELINE COMPARISONS